BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Mental Health Issues in Pediatric Neuromuscular Disease

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Wednesday, December 9, 2020
Expiration Date: 
Friday, December 8, 2023
Sponsor Information: 

This program is supported in part by an independent medical education grant from Mitsubishi Tanabe Pharma America, Inc. and Biogen.

Faculty

Avavindhan Veerapandiyan, MD
Avavindhan Veerapandiyan, MD
Pediatric Neurologist - Arkansas Children's Hospital
Hillary Zebberman
Hillary Zebberman
Clinical Social Worker - Center for Duchenne Muscular Dystrophy, ALS Neuromuscular Clinic, Pediatric Metobolic Genetics UCLA
Pediatric Mental Health Grand Round
Activity Overview: 

Hillary Zebberman from the Pediatric Neuromuscular Clinic at UCLA and Aravindhan Veerapandiyan from Arkansas Children’s Hospital provide an overview of best practices in mental health care for pediatric patients with neuromuscular disease (NMD). The webinar includes an overview of the biological and psychosocial issues that impact the mental health and emotional needs of adolescents, as well as guidance on assessing the mental health needs of this population and incorporating these considerations into the treatment plan.

Learning Objectives: 
  • Identify unique aspects of psychosocial care in the pediatric neuromuscular disease (NMD) patient population ​
  • Incorporate management of psychological concerns and optimal support considerations into the treatment plan ​
  • Understand the contributors to mental health issues, including the emotional needs of adolescent individuals
Accreditation and Designation Statement: 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and Muscular Dystrophy Association. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.

The PeerPoint Medical Education Institute, LLC designates this Enduring material activity for .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Obtain CME credits : 

Once you have viewed the program, MDA will share back with you instructions for how to obtain your CME credits. If you have questions on this process, please reach out to cmemanagement@mdausa.org.

Faculty Disclosures: 

All presenters, planners, editors, or staff reported no relevant relationships with the following statement:

"I, or an immediate family member, do not have at present, or within the last 12 months, nor anticipate having financial interest, arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities."